Navigation Links
Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine
Date:10/12/2009

SAN MARINO, Calif., Oct. 12 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic. Administered as stand-alone therapy in late-stage cases of chemotherapy-resistant cancer, Rexin-G has once again accomplished what standard cancer treatments and even much-touted biologics have failed to do: that is, to bring forth the benefits of remission in otherwise intractable metastatic cancers. Three recent cases of Stage IV metastatic cancer, namely (i) osteosarcoma, (ii) prostate cancer, and (iii) pancreas cancer, demonstrated that Rexin-G treatments alone led to clinical remission of disease in each of these poor prognosis patients. Even more remarkable, perhaps, are the profiles of the latter two patients, which signal the advent of Rexin-G as the vanguard of a new class of exceedingly precise, selective, and effective anti-cancer agents, and which typify a newfound societal acceptance and acknowledgement of the real-world promise and potential of this uniquely-targeted genetic medicine.

Remarkably, a Catholic priest, who was previously bedridden and in withering pain, suffering from end-stage prostate cancer that had spread to his bones, received successive courses of Rexin-G, during which time the bone pain was relieved, the PSA tumor markers fell, the bone tumors stopped growing, and even the previously inoperable primary tumor disappeared on follow-up CT scans. As the priest's bones began to heal and strengthen, he arose from his bed and is currently saying daily Mass and delivering lectures in the seminary. What is even more remarkable is that this revered man of the cloth was over ninety years old at the time of his treatment and remission. This past week, the latest good news comes from the trenches of Stage IVb pancreas cancer, where a complete clinical remission was
'/>"/>

SOURCE Epeius Biotechnologies Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)
2. Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix
3. New approach for growing bone comes from Duke preclinical research
4. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
5. Clinical Genomics Continues Collaborative Research With CSIRO
6. HerbalScience Releases Results of Pilot Clinical Study on Efficacy of Its Proprietary Elderberry Extract in Addressing Flu-Like Symptoms
7. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
8. Medicago begins human clinical testing with its avian flu pandemic vaccine
9. MacuSight(R) Provides Clinical Development Update for Perceiva(TM)
10. Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers
11. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... SYDNEY , April 17, 2015  US-Australian drug ... signed a Memorandum of Understanding with the Feinstein ... New York to collaborate with ... cancers. The collaboration brings together the ... and clinical expertise of the Feinstein Institute in ...
(Date:4/17/2015)... 17, 2015 BellBrook Labs announced ... support for the powerful Orthogonal Pooled Screening (OPS) ... Center at the Lankenau Institute for Medical Research ... to measurably improve successful drug discovery outcomes using ... rare, drug-like libraries available nowhere else, coupled to ...
(Date:4/16/2015)... April 16, 2015 Cambridge ... solutions driven by Semantic Web technology, and ... information and services for the academic and scientific, ... its joint solution ‘Smart Data Lake for Clinical ... for the 2015 Bio-IT ‘Best of Show’ Award. ...
(Date:4/16/2015)... 16, 2015 Proove Biosciences , ... of BIO Contest for the 2015 BIO International ... 2015 BIO International Convention will take place June 15-18 ... the Buzz of BIO contest, industry leaders will be ... at the conference. The community voting period began on ...
Breaking Biology Technology:Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3
... ... Executive Officer of Merrimack Pharmaceuticals, will provide a company overview at the Jefferies 2010 ... ... announced that it will present at the Jefferies 2010 Global Life Sciences Conference in ...
... A team of Duke University chemists has perfected a simple ... conductors are small enough to be transparent, making them ideal ... displays. "Imagine a foldable iPad," said Benjamin Wiley, an ... findings online this week in Advanced Materials . ...
... CHAPEL HILL, N.C. , June 1 Companies invest hundreds of ... these new products to market.   , , ... on these vast investments, successful companies must maximize product uptake across all customer groups: ... win formulary access and improve product placement.   , ...
Cached Biology Technology:Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference 2Copper nanowires enable bendable displays and solar cells 2Maximize Market Research to Improve Formulary Access Within Managed Markets Sector 2Maximize Market Research to Improve Formulary Access Within Managed Markets Sector 3
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... that rise from oil fields, topped with burning flames ... dioxide into the air. In new work, researchers have ... turn methane into a safe and easy-to-transport liquid. The ... a variety of useful fuels and chemicals. "There,s ...
... NY Babies born preterm were more than twice as ... to a new analysis of nearly 7 million U.S. live ... and Child Health Journal. Preterm birth, live birth ... crisis, according to the March of Dimes. More than a ...
... College have received a five-year, $11.6 million grant from ... molecular mechanisms of cardiac injury that lead to heart ... adult failing heart. This project aims to find data ... improve the failing heart. This study ...
Cached Biology News:Halting methane squanderlust 2Halting methane squanderlust 3Analysis of millions of US births shows association between birth defects and preterm birth 2Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure 2Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure 3
... LabX light balance makes your life easier. It offers ... and management for one balance. *Instruments supported: ... AX, MX, UMX, AG, XS, XP, PR, SR, PG-S, ... *Job management: User ...
... ,Components g/500 ml: ,Tryptone ... chloride 2.5 ,Agar 6.0 ,S-Gal ... ,IPTG 0.025 ,Kanamycin 0.0175 ... complete growth medium containing S-Gal ...
... Group combines deep experience, skills and flexibility ... collaborative team chemistry. This combination enables optimum ... and beyond.,With AAIBiotech, you can count on ... more than that: its the power of ...
... Physical form: Lyophilized ... salts Preparation Unit Definition: ... 1.0μmole of 2-phosphoglycerate to ... pH7.4 at 25 C. ...
Biology Products: